Norvir 100 mg TABLET, Powder for Oral Suspension
PDF Leaflet Revision Date: 24 January 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Used as a pharmacokinetic enhancer of certain antiretroviral protease inhibitors.
Dosage (summary)
Adults: Consult specific protease inhibitor guidelines. Pediatric: 400 mg/mu00b2 twice daily, max 600 mg.
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; safety not established.
Key Drug Interactions
- CYP3A4 inhibitors
- Sedative/hypnotics
- Antidysrhythmics
Contraindications
- Hypersensitivity to ritonavir
- Severe liver disease
- Rifampicin regimens
Common side effects
- Nausea
- Diarrhea
- Vomiting
- Abdominal pain
- Taste perversion
Counselling Points
- Take with food
- Monitor for liver function
- Avoid St. John's Wort
Serious warnings
- Serious hepatic reactions
- Pancreatitis risk
- Diabetes mellitus
Important Disclaimer
The Norvir 100 mg TABLET, Powder for Oral Suspension professional information leaflet below is the property of AbbVie and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
